Cross Country Healthcare (CCRN) EBITDA (2010 - 2026)

Cross Country Healthcare (CCRN) has reported EBITDA for 17 consecutive years, with -$4.4 million the latest figure, recorded in Q1 2026.

• EBITDA for Q1 2026 came in at -$4.4 million, down 806.19% year-over-year; the trailing twelve-month figure through Mar 2026 was -$98.9 million (down 455.95% YoY), and the FY2025 annual result was -$95.0 million, down 549.95% from the prior year.
• EBITDA was -$4.4 million for Q1 2026 at Cross Country Healthcare, up from -$83.0 million in the prior quarter.
• Over five years, EBITDA peaked at $62.0 million in Q1 2022 and troughed at -$83.0 million in Q4 2025.
• Average EBITDA over 5 years is $8.5 million, with a median of $2.7 million recorded in 2024.
• Year-over-year, EBITDA surged 358.72% in 2022 and plunged 2084.96% in 2025.
• Over 5 years, EBITDA stood at $36.3 million in 2022, then plunged by 75.08% to $9.0 million in 2023, then tumbled by 141.97% to -$3.8 million in 2024, then slumped by 2084.96% to -$83.0 million in 2025, then jumped by 94.7% to -$4.4 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were -$4.4 million in Q1 2026, -$83.0 million in Q4 2025, and -$4.9 million in Q3 2025.